Reduction of Serum Lipid Profile by Escitalopram in Depressive Patients: A Cardio Protective Aspect of SSRI Use-Juniper Publishers
JUNIPER PUBLISHERS-OPEN ACCESS JOURNAL OF CARDIOLOGY & CARDIOVASCULAR THERAPY Abstract Background: Depression is disturbance of mood, speech and thoughts interfering with the individual’s social life and negatively affecting the family and thus the whole society. Suicide is the most horrible complication ending the life of the patient. Escitalopram belongs to the SSRIs, the most commonly used group of antidepressants worldwide. Objective: To explore the effects of Escitalopram treatment on lipid profile in patients with depression. Methodology: This experimental study of 6 months duration was conducted in Sir C.J Institute of Psychiatry Hyderabad and Isra Research Laboratory from July 2016 to December 2016. 72 diagnosed patients of depression were selected through non probability purposive sampling. After ethical approval and informed consent blood sample were collected under a septic measures. Samples were analyzed for total cholesterol, HDL, LDL and TAGs...